Evidence lacking for hub & spoke says NPA

Latest

Evidence lacking for hub & spoke says NPA

In Latest

There is little existing evidence that hub and spoke dispensing saves money or improves patient safety in community pharmacies, the National Pharmacy Association claimed as it published new research.

In a 99-page report published yesterday (February 25), the NPA also said that despite the technology that enables large scale automated dispensing having been available for at least 15 years, its use “remains very limited globally”.

The report looks at how automated dispensing is deployed in a number of northern European countries including the UK, as well as north America, Australia and South Africa.

The publication of the report came days after the NHS, PSNC and Department of Health and Social Care announced that the second year of the Community Pharmacy Contractual Framework would see further work done to try and roll out hub and spoke dispensing across England.

Economic case ‘absent’

The NPA said that as yet there are no large-scale hubs serving hundreds of pharmacies or more, and that most central dispensing is done with loose pills (the Netherlands is the only country to use automated dispensing for original packs on a significant scale).

The report also noted that several academics have identified the absence of a cost-benefit case for large scale automated dispensing and that an evidenced economic case would therefore be “welcome”.

And despite automation potentially making some parts of the dispensing process more accurate, the NPA said there was no “definitive evidence” that third-party dispensing improves patient safety outcomes.

This was because introducing automation creates a need for new processes in other parts of the dispensing chain, and as yet no studies “address the patient safety impact of the full end-to-end process”.

Academic researchers have been “much more conservative” regarding the impact automated dispensing has on patient safety than some of those advocating the practice, said the NPA.

‘Serious questions’

NPA head of corporate affairs Gareth Jones said: “Independent data and evidence does not clearly establish either an economic case or a health outcomes case for large scale automation.

“That doesn’t mean there is no future for hub and spoke, but it should give policy makers pause for thought.

“It raises serious questions about the underlying case for investing in models that allow hub and spoke to operate between different companies.”

Record my learning outcomes

Latest

Inspiring stories related to health, fitness and the pursuit of wellbeing

Share:

More like this

bookmark_icon_off
Latest

All change at RPS Scotland

Director and deputy to retire in 2020.

1 Min Article

bookmark_icon_off
Latest

Most side effects of statins down to 'nocebo effect'

Most of the side-effects people suffer after taking statins are due to their negative associations with the drug, researchers have found.

 

1 Min Article

bookmark_icon_off
Latest

First NHS report on lesbian, gay and bisexual health

The report found LGB adults are more likely than heterosexuals to report having a limiting longstanding illness.

1 Min Article

bookmark_icon_off
Latest

RPS president apologises for comments on BAME discrimination

RPS president Sandra Gidley apologised for recent comments concerning efforts to tackle discrimination against BAME pharmacists.

1 Min Article

bookmark_icon_off
Latest

Boots partners with private electronic prescriptions provider

Boots UK is partnering with online GP consultation provider Doctor Care Anywhere (DCA) in a London pilot.

1 Min Article

bookmark_icon_off
Latest

Parents told to keep child vaccine appointments during second lockdown

Parents have been urged to ensure children receive routine vaccinations during the latest lockdown.

1 Min Article

Recommended Learning

bookmark_icon_off
Sponsored education

Skincare training for pharmacy

Delve into dry skin management and understand how you can make a difference to customers looking for advice, support and product recommendations to help manage their compromised skin.

15 Min Module

bookmark_icon_off
Sponsored education

Advising on stimulant laxatives

Safely recommend the most effective laxative for every customer with constipation

15 Min Module

bookmark_icon_off
Sponsored education

Pain conversations - making effective recommendations

Explore our detailed case studies to help understand how to advise customers on different causes of pain.

15 Min Module

Sponsored education

Advising on very dry and eczema-prone skin

This video will guide you through a consultation with Michelle, a customer with very dry skin, and help you recommend suitable products to help

2 Min Module

Sponsored education

The person behind the patient

This interactive video will introduce three patients with erection problems (EPs) and ask you to work out what the causes might be and how you can help.

4 Min Module

bookmark_icon_off
Sponsored education

Sore throat treatment update

Update your knowledge on treating sore throat without antibiotics with this short, interactive module.

10 Min Module